Development  ||| S:0 E:12 ||| NN
of  ||| S:12 E:15 ||| IN
gray  ||| S:15 E:20 ||| JJ
matter  ||| S:20 E:27 ||| NN
atrophy  ||| S:27 E:35 ||| NN
in  ||| S:35 E:38 ||| IN
relapsing-remitting  ||| S:38 E:58 ||| JJ
multiple  ||| S:58 E:67 ||| JJ
sclerosis  ||| S:67 E:77 ||| NN
is  ||| S:77 E:80 ||| VBZ
not  ||| S:80 E:84 ||| RB
gender  ||| S:84 E:91 ||| VB
dependent ||| S:91 E:100 ||| JJ
:  ||| S:100 E:102 ||| :
results  ||| S:102 E:110 ||| NNS
of  ||| S:110 E:113 ||| IN
a  ||| S:113 E:115 ||| DT
5-year  ||| S:115 E:122 ||| JJ
follow-up  ||| S:122 E:132 ||| JJ
study  ||| S:132 E:138 ||| NN
The  ||| S:138 E:142 ||| DT
aim  ||| S:142 E:146 ||| NN
of  ||| S:146 E:149 ||| IN
this  ||| S:149 E:154 ||| DT
study  ||| S:154 E:160 ||| NN
was  ||| S:160 E:164 ||| VBD
to  ||| S:164 E:167 ||| TO
explore  ||| S:167 E:175 ||| VB
the  ||| S:175 E:179 ||| DT
evolution  ||| S:179 E:189 ||| NN
of  ||| S:189 E:192 ||| IN
MRI  ||| S:192 E:196 ||| NNP
related  ||| S:196 E:204 ||| JJ
gender  ||| S:204 E:211 ||| NN
differences  ||| S:211 E:223 ||| NNS
in  ||| S:223 E:226 ||| IN
patients  ||| S:226 E:235 ||| NNS
with  ||| S:235 E:240 ||| IN
relapsing-remitting  ||| S:240 E:260 ||| NNP
( ||| S:260 E:261 ||| -LRB-
RR ||| S:261 E:263 ||| NNP
)  ||| S:263 E:265 ||| -RRB-
multiple  ||| S:265 E:274 ||| JJ
sclerosis  ||| S:274 E:284 ||| NNS
( ||| S:284 E:285 ||| -LRB-
MS ||| S:285 E:287 ||| NNP
)  ||| S:287 E:289 ||| -RRB-
who  ||| S:289 E:293 ||| WP
participated  ||| S:293 E:306 ||| VBD
in  ||| S:306 E:309 ||| IN
a  ||| S:309 E:311 ||| DT
clinical  ||| S:311 E:320 ||| JJ
trial  ||| S:320 E:326 ||| NN
over  ||| S:326 E:331 ||| IN
the  ||| S:331 E:335 ||| DT
5  ||| S:335 E:337 ||| CD
years.  ||| S:337 E:344 ||| CD
181  ||| S:344 E:348 ||| CD
patients  ||| S:348 E:357 ||| NNS
( ||| S:357 E:358 ||| -LRB-
39  ||| S:358 E:361 ||| CD
males  ||| S:361 E:367 ||| NNS
and  ||| S:367 E:371 ||| CC
142  ||| S:371 E:375 ||| CD
females ||| S:375 E:382 ||| NNS
)  ||| S:382 E:384 ||| -RRB-
were  ||| S:384 E:389 ||| VBD
assessed  ||| S:389 E:398 ||| VBN
for  ||| S:398 E:402 ||| IN
clinical  ||| S:402 E:411 ||| JJ
and  ||| S:411 E:415 ||| CC
neuroradiological  ||| S:415 E:433 ||| JJ
disease  ||| S:433 E:441 ||| NN
activity  ||| S:441 E:450 ||| NN
over  ||| S:450 E:455 ||| IN
a  ||| S:455 E:457 ||| DT
period  ||| S:457 E:464 ||| NN
of  ||| S:464 E:467 ||| IN
5  ||| S:467 E:469 ||| CD
years ||| S:469 E:474 ||| NNS
.  ||| S:474 E:476 ||| .
Clinical  ||| S:476 E:485 ||| JJ
and  ||| S:485 E:489 ||| CC
MRI  ||| S:489 E:493 ||| NNP
examination  ||| S:493 E:505 ||| NN
were  ||| S:505 E:510 ||| VBD
performed  ||| S:510 E:520 ||| VBN
at  ||| S:520 E:523 ||| IN
the  ||| S:523 E:527 ||| DT
baseline ||| S:527 E:535 ||| NN
,  ||| S:535 E:537 ||| ,
6 ||| S:537 E:538 ||| CD
,  ||| S:538 E:540 ||| ,
12 ||| S:540 E:542 ||| CD
,  ||| S:542 E:544 ||| ,
24 ||| S:544 E:546 ||| CD
,  ||| S:546 E:548 ||| ,
36 ||| S:548 E:550 ||| CD
,  ||| S:550 E:552 ||| ,
48  ||| S:552 E:555 ||| CD
and  ||| S:555 E:559 ||| CC
60  ||| S:559 E:562 ||| CD
months ||| S:562 E:568 ||| NNS
.  ||| S:568 E:570 ||| .
Longitudinal  ||| S:570 E:583 ||| JJ
percentage  ||| S:583 E:594 ||| NN
volume  ||| S:594 E:601 ||| NN
changes  ||| S:601 E:609 ||| NNS
in  ||| S:609 E:612 ||| IN
whole  ||| S:612 E:618 ||| JJ
brain  ||| S:618 E:624 ||| NN
( ||| S:624 E:625 ||| -LRB-
PBVC ||| S:625 E:629 ||| NNP
) ||| S:629 E:630 ||| -RRB-
,  ||| S:630 E:632 ||| ,
gray  ||| S:632 E:637 ||| JJ
matter  ||| S:637 E:644 ||| NN
( ||| S:644 E:645 ||| -LRB-
PGMVC ||| S:645 E:650 ||| NNP
)  ||| S:650 E:652 ||| -RRB-
white  ||| S:652 E:658 ||| JJ
matter  ||| S:658 E:665 ||| NN
( ||| S:665 E:666 ||| -LRB-
PWMVC ||| S:666 E:671 ||| NNP
)  ||| S:671 E:673 ||| -RRB-
cortex  ||| S:673 E:680 ||| NNS
( ||| S:680 E:681 ||| -LRB-
PCVC ||| S:681 E:685 ||| NNP
) ||| S:685 E:686 ||| -RRB-
,  ||| S:686 E:688 ||| ,
and  ||| S:688 E:692 ||| CC
lateral  ||| S:692 E:700 ||| JJ
ventricles  ||| S:700 E:711 ||| NNS
( ||| S:711 E:712 ||| -LRB-
PLVVC ||| S:712 E:717 ||| NNP
)  ||| S:717 E:719 ||| -RRB-
were  ||| S:719 E:724 ||| VBD
calculated  ||| S:724 E:735 ||| VBN
by  ||| S:735 E:738 ||| IN
using  ||| S:738 E:744 ||| VBG
direct  ||| S:744 E:751 ||| JJ
methods  ||| S:751 E:759 ||| NNS
( ||| S:759 E:760 ||| -LRB-
SIENA  ||| S:760 E:766 ||| NNP
and  ||| S:766 E:770 ||| CC
SIENAX-multitimepoint ||| S:770 E:791 ||| NNP
) ||| S:791 E:792 ||| -RRB-
.  ||| S:792 E:794 ||| .
Absolute  ||| S:794 E:803 ||| JJ
tissue  ||| S:803 E:810 ||| NN
volume  ||| S:810 E:817 ||| NN
changes  ||| S:817 E:825 ||| NNS
of  ||| S:825 E:828 ||| IN
subcortical  ||| S:828 E:840 ||| JJ
deep  ||| S:840 E:845 ||| JJ
GM  ||| S:845 E:848 ||| NNP
structures  ||| S:848 E:859 ||| NNS
including  ||| S:859 E:869 ||| VBG
caudate ||| S:869 E:876 ||| NN
,  ||| S:876 E:878 ||| ,
putamen ||| S:878 E:885 ||| NN
,  ||| S:885 E:887 ||| ,
globus  ||| S:887 E:894 ||| JJ
pallidus ||| S:894 E:902 ||| NN
,  ||| S:902 E:904 ||| ,
thalamus ||| S:904 E:912 ||| NN
,  ||| S:912 E:914 ||| ,
hippocampus ||| S:914 E:925 ||| NN
,  ||| S:925 E:927 ||| ,
amygdala  ||| S:927 E:936 ||| NN
and  ||| S:936 E:940 ||| CC
nucleus  ||| S:940 E:948 ||| JJ
accumbens  ||| S:948 E:958 ||| NN
were  ||| S:958 E:963 ||| VBD
estimated  ||| S:963 E:973 ||| VBN
using  ||| S:973 E:979 ||| VBG
FIRST ||| S:979 E:984 ||| RB
,  ||| S:984 E:986 ||| ,
a  ||| S:986 E:988 ||| DT
model  ||| S:988 E:994 ||| NN
based  ||| S:994 E:1000 ||| VBN
segmentation ||| S:1000 E:1012 ||| CD
/ ||| S:1012 E:1013 ||| CD
registration  ||| S:1013 E:1026 ||| NN
tool ||| S:1026 E:1030 ||| NN
.  ||| S:1030 E:1032 ||| .
T2  ||| S:1032 E:1035 ||| NNP
lesion  ||| S:1035 E:1042 ||| JJ
volume  ||| S:1042 E:1049 ||| NN
( ||| S:1049 E:1050 ||| -LRB-
T2-LV ||| S:1050 E:1055 ||| NNP
)  ||| S:1055 E:1057 ||| -RRB-
and  ||| S:1057 E:1061 ||| CC
lesion  ||| S:1061 E:1068 ||| JJ
activity  ||| S:1068 E:1077 ||| NN
analyses  ||| S:1077 E:1086 ||| NNS
were  ||| S:1086 E:1091 ||| VBD
performed ||| S:1091 E:1100 ||| VBN
,  ||| S:1100 E:1102 ||| ,
using  ||| S:1102 E:1108 ||| VBG
a  ||| S:1108 E:1110 ||| DT
contouring-threshold  ||| S:1110 E:1131 ||| JJ
and  ||| S:1131 E:1135 ||| CC
subtraction  ||| S:1135 E:1147 ||| JJ
techniques ||| S:1147 E:1157 ||| NNS
.  ||| S:1157 E:1159 ||| .
All  ||| S:1159 E:1163 ||| DT
clinical  ||| S:1163 E:1172 ||| JJ
and  ||| S:1172 E:1176 ||| CC
MRI  ||| S:1176 E:1180 ||| NNP
variables  ||| S:1180 E:1190 ||| NNS
were  ||| S:1190 E:1195 ||| VBD
analyzed  ||| S:1195 E:1204 ||| VBN
between  ||| S:1204 E:1212 ||| IN
males  ||| S:1212 E:1218 ||| NNS
and  ||| S:1218 E:1222 ||| CC
females ||| S:1222 E:1229 ||| NNS
.  ||| S:1229 E:1231 ||| .
Global  ||| S:1231 E:1238 ||| NNP
( ||| S:1238 E:1239 ||| -LRB-
PBVC ||| S:1239 E:1243 ||| NNP
)  ||| S:1243 E:1245 ||| -RRB-
and  ||| S:1245 E:1249 ||| CC
tissue  ||| S:1249 E:1256 ||| NN
specific  ||| S:1256 E:1265 ||| NN
( ||| S:1265 E:1266 ||| -LRB-
PGMVC ||| S:1266 E:1271 ||| NNP
,  ||| S:1271 E:1273 ||| ,
PWMVC ||| S:1273 E:1278 ||| NNP
,  ||| S:1278 E:1280 ||| ,
PCVC ||| S:1280 E:1284 ||| NNP
,  ||| S:1284 E:1286 ||| ,
PLVVC ||| S:1286 E:1291 ||| NNP
)  ||| S:1291 E:1293 ||| -RRB-
brain  ||| S:1293 E:1299 ||| NN
volume  ||| S:1299 E:1306 ||| NN
changes  ||| S:1306 E:1314 ||| NNS
showed  ||| S:1314 E:1321 ||| VBD
no  ||| S:1321 E:1324 ||| DT
significant  ||| S:1324 E:1336 ||| JJ
gender  ||| S:1336 E:1343 ||| NN
differences  ||| S:1343 E:1355 ||| NNS
over  ||| S:1355 E:1360 ||| IN
the  ||| S:1360 E:1364 ||| DT
5-year  ||| S:1364 E:1371 ||| JJ
follow-up  ||| S:1371 E:1381 ||| JJ
period ||| S:1381 E:1387 ||| NN
.  ||| S:1387 E:1389 ||| .
Although  ||| S:1389 E:1398 ||| IN
total  ||| S:1398 E:1404 ||| JJ
subcortical  ||| S:1404 E:1416 ||| JJ
deep  ||| S:1416 E:1421 ||| JJ
GM ||| S:1421 E:1423 ||| NNP
,  ||| S:1423 E:1425 ||| ,
caudate ||| S:1425 E:1432 ||| NN
,  ||| S:1432 E:1434 ||| ,
putamen ||| S:1434 E:1441 ||| NN
,  ||| S:1441 E:1443 ||| ,
globus  ||| S:1443 E:1450 ||| JJ
palidus ||| S:1450 E:1457 ||| NN
,  ||| S:1457 E:1459 ||| ,
thalamus  ||| S:1459 E:1468 ||| NN
and  ||| S:1468 E:1472 ||| CC
nucleus  ||| S:1472 E:1480 ||| JJ
accumbens  ||| S:1480 E:1490 ||| JJ
normalized  ||| S:1490 E:1501 ||| JJ
volumes  ||| S:1501 E:1509 ||| NNS
were  ||| S:1509 E:1514 ||| VBD
significantly  ||| S:1514 E:1528 ||| RB
larger  ||| S:1528 E:1535 ||| JJR
in  ||| S:1535 E:1538 ||| IN
male  ||| S:1538 E:1543 ||| JJ
subjects  ||| S:1543 E:1552 ||| NNS
at  ||| S:1552 E:1555 ||| IN
baseline ||| S:1555 E:1563 ||| NN
,  ||| S:1563 E:1565 ||| ,
the  ||| S:1565 E:1569 ||| DT
follow-up  ||| S:1569 E:1579 ||| JJ
analysis  ||| S:1579 E:1588 ||| NN
showed  ||| S:1588 E:1595 ||| VBD
no  ||| S:1595 E:1598 ||| DT
differences  ||| S:1598 E:1610 ||| NNS
over  ||| S:1610 E:1615 ||| IN
the  ||| S:1615 E:1619 ||| DT
5  ||| S:1619 E:1621 ||| CD
years ||| S:1621 E:1626 ||| NNS
.  ||| S:1626 E:1628 ||| .
There  ||| S:1628 E:1634 ||| EX
were  ||| S:1634 E:1639 ||| VBD
no  ||| S:1639 E:1642 ||| DT
gender  ||| S:1642 E:1649 ||| NN
differences  ||| S:1649 E:1661 ||| NNS
in  ||| S:1661 E:1664 ||| IN
lesion  ||| S:1664 E:1671 ||| JJ
activity  ||| S:1671 E:1680 ||| NN
or  ||| S:1680 E:1683 ||| CC
T2-LV  ||| S:1683 E:1689 ||| CD
changes  ||| S:1689 E:1697 ||| NNS
over  ||| S:1697 E:1702 ||| IN
the  ||| S:1702 E:1706 ||| DT
5  ||| S:1706 E:1708 ||| CD
years ||| S:1708 E:1713 ||| NNS
.  ||| S:1713 E:1715 ||| .
No  ||| S:1715 E:1718 ||| DT
MRI  ||| S:1718 E:1722 ||| NNP
lesion ||| S:1722 E:1728 ||| NN
,  ||| S:1728 E:1730 ||| ,
global ||| S:1730 E:1736 ||| JJ
,  ||| S:1736 E:1738 ||| ,
tissue  ||| S:1738 E:1745 ||| NN
specific  ||| S:1745 E:1754 ||| JJ
or  ||| S:1754 E:1757 ||| CC
regional  ||| S:1757 E:1766 ||| JJ
brain  ||| S:1766 E:1772 ||| NN
volume  ||| S:1772 E:1779 ||| NN
gender  ||| S:1779 E:1786 ||| NN
change  ||| S:1786 E:1793 ||| NN
differences  ||| S:1793 E:1805 ||| NNS
were  ||| S:1805 E:1810 ||| VBD
found  ||| S:1810 E:1816 ||| VBN
over  ||| S:1816 E:1821 ||| IN
the  ||| S:1821 E:1825 ||| DT
5-year  ||| S:1825 E:1832 ||| NNP
follow-up ||| S:1832 E:1841 ||| NNP
.  ||| S:1841 E:1843 ||| .
